User profiles for Henry Kyobe Bosa

Henry Kyobe Bosa

Ministry of Health, Uganda; Universisty of Oxford
Verified email at kellogg.ox.ac.uk
Cited by 579

[HTML][HTML] Field evaluation of the performance of a SARS-CoV-2 antigen rapid diagnostic test in Uganda using nasopharyngeal samples

…, I Ssewanyana, D Atwine, H Mwebesa, HK Bosa… - International Journal of …, 2021 - Elsevier
Objectives There is a high demand for SARS-CoV-2 testing to identify COVID-19 cases.
Real-time, quantitative PCR (qRT-PCR) is the recommended diagnostic test but a number of …

Outbreak of yellow fever in central and southwestern Uganda, February–May 2016

L Kwagonza, B Masiira, H Kyobe-Bosa… - BMC infectious …, 2018 - Springer
Background On 28 March, 2016, the Ministry of Health received a report on three deaths
from an unknown disease characterized by fever, jaundice, and hemorrhage which occurred …

Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches–March-April 2020

…, JJ Lutwama, AL Boore, JR Harris, HK Bosa… - Globalization and …, 2020 - Springer
Background On March 13, 2020, Uganda instituted COVID-19 symptom screening at its
international airport, isolation and SARS-CoV-2 testing for symptomatic persons, and mandatory …

Multidistrict outbreak of Marburg virus disease—Uganda, 2012

…, Y Boum, I Makumbi, HK Bosa… - The Journal of …, 2015 - academic.oup.com
In October 2012, a cluster of illnesses and deaths was reported in Uganda and was confirmed
to be an outbreak of Marburg virus disease (MVD). Patients meeting the case criteria were …

Leveraging the structures of the COVID-19 pandemic response for successful control of Ebola in Uganda

H Kyobe Bosa, MK Njenga, M Wayengera, B Kirenga… - Nature Medicine, 2023 - nature.com
Africa in 2013–2016, the World Health Organization (WHO) fast-tracked the development and
testing of therapeutic agents and vaccines against the Zaire strain, the causative agent 1–5…

[HTML][HTML] Building critical care capacity in a low-income country

…, A Alenyo-Ngabirano, H Kyobe-Bosa… - Critical Care …, 2022 - ncbi.nlm.nih.gov
Among people with COVID-19 about 5% have critical disease with complications such as
respiratory failure, acute respiratory distress syndrome (ARDS), severe sepsis and septic shock…

COVID-19 immune signatures in Uganda persist in HIV co-infection and diverge by pandemic phase

…, I Nayiga, S Kyebambe, M Haumba, HK Bosa… - Nature …, 2024 - nature.com
Little is known about the pathobiology of SARS-CoV-2 infection in sub-Saharan Africa, where
severe COVID-19 fatality rates are among the highest in the world and the immunological …

Standard of care for viral haemorrhagic fevers (VHFs): a systematic review of clinical management guidelines for high-priority VHFs

…, H Groves, P Hart, M Cevik, HK Bosa… - The Lancet Infectious …, 2023 - thelancet.com
The Sudan virus disease outbreak in Uganda in 2022 showed our vulnerability to viral
haemorrhagic fevers (VHFs). Although there are regular outbreaks of VHFs with high morbidity …

Epidemiology, clinical characteristics, and mortality of hospitalized patients with severe COVID-19 in Uganda, 2020–2021

…, I Nayiga, S Kyebambe, H Kyobe Bosa… - Annals of the …, 2022 - atsjournals.org
Methods This study was conducted at Entebbe Regional Referral Hospital (ERRH), a 200-bed
public hospital in central Uganda, from March 22, 2020 to November 30, 2021. During this …

Shifting transmission patterns of human mpox in South Kivu, DR Congo

…, E Bahizire, EB Malembaka, HK Bosa… - The Lancet Infectious …, 2024 - thelancet.com
In the wake of the COVID-19 pandemic, humanity experienced the emergence of another
epidemic health threat in 2022. That threat came from human mpox (formerly known as …